Chester County News and Community Website
SANTA MONICA, CA & PHILADELPHIA, PA — Kite, a Gilead company (Nasdaq: GILD), has agreed to acquire Interius BioTherapeutics for $350 million in cash, a move aimed at bringing in …
Kite to Buy Interius BioTherapeutics for $350 Million, Advancing In Vivo CAR T Strategy Read More
PHILADELPHIA, PA — Interius BioTherapeutics has announced its participation in three key scientific gatherings this spring, where the company will spotlight its advancements in in vivo gene and cell therapy. …
Interius BioTherapeutics Highlights Innovative Therapies at Upcoming Conferences Read More
PHILADELPHIA, PA — Interius BioTherapeutics has secured approval from Germany’s Paul Ehrlich Institute (PEI) to expand its pioneering INVISE Phase 1 clinical trial into Europe. This marks the first-ever clearance …
Interius BioTherapeutics Expands Groundbreaking Gene Therapy Trial to Europe Read More
PHILADELPHIA, PA — Interius BioTherapeutics has taken a significant step forward with the dosing of its first participant in the Phase 1 clinical trial of INT2104, a pioneering gene therapy designed …
Interius BioTherapeutics Launches Innovative Gene Therapy Trial for B-Cell Malignancies Read More